Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies. uri icon

Overview

publication date

  • February 12, 2018

Research

keywords

  • Autoantibodies
  • Colonic Neoplasms
  • Oxaliplatin
  • Purpura, Thrombocytopenic, Idiopathic
  • Stomach Neoplasms

Identity

PubMed Central ID

  • PMC5877442

Scopus Document Identifier

  • 85047628793

Digital Object Identifier (DOI)

  • 10.1182/blood-2017-10-812461

PubMed ID

  • 29439950

Additional Document Info

volume

  • 131

issue

  • 13